NIH director nominee is Francis Collins
This article was originally published in The Gray Sheet
Executive Summary
Physician-geneticist Francis S. Collins, President Obama's choice to direct the National Institutes of Health, is an expert on and ambitious proponent of personalized medicine, as showcased by his latest book, The Language of Life: DNA and the Revolution in Personalized Medicine (due to be published in 2010). Collins directed NIH's National Human Genome Research Institute from 1993-2008, which resulted in the mapping of the human genome and helped usher in the era of personalized medicine. In that role, Collins "consistently met projected milestones ahead of schedule and under budget," the White House notes in a July 8 statement. AdvaMed applauded the nomination, noting the central role of molecular diagnostic research in personalized medicine
You may also be interested in...
Changes To EU Pharma Reform: More Questions Than Answers?
In the first of a series of articles on the future direction of the EU pharmaceutical reform proposals, the Pink Sheet looks at the new uncertainties created for the drug industry after the European Parliament voted through a series of amendments in the area of regulatory data protection.
Probiotics And Cold Remedies Boost Recordati In 2023
Italy's Recordati saw its OTC sales grow by 10% in 2023 driven by the recovery of the cough & cold market and a growing demand for probiotics.
Falling Sales Force New Priorities At Roche
The Swiss major brings a new ruthlessness to the compounds in its pipeline: if they’re not first or best, they’re out.